Artificial intelligence is becoming increasingly common across pharmaceutical, biotechnology, clinical research, laboratory, and other regulated environments. From data analysis and quality processes to manufacturing and safety activities, AI software can support important GxP operations.
However, using AI in a regulated environment requires more than checking whether the software works as expected. Organizations must determine whether the system is appropriately controlled, documented, validated, secure, and suitable for its intended GxP use.
Knowing how to assess AI software compliance in a GxP environment helps organizations identify potential risks before they affect product quality, patient safety, data integrity, or regulatory compliance.
What Is AI Software Compliance in a GxP Environment?
AI software compliance refers to the process of evaluating whether an AI-enabled application meets applicable GxP requirements and organizational quality standards.
Unlike conventional computerized systems, AI applications can involve machine learning models, changing datasets, probabilistic outputs, model updates, and complex decision-making processes. Therefore, an AI software assessment should consider both traditional computerized system controls and AI-specific risks.
The assessment may cover:
- Intended use and GxP impact
- AI and machine learning functionality
- Data quality and integrity
- Model development and validation
- Human oversight
- System security and access controls
- Audit trails
- Change management
- Documentation and governance
- Regulatory requirements
Also read: AI Software Compliance Audits in Pharma: Complete 2026 Guide
Step 1: Understand the AI Software and Its Intended Use
The first step to assess AI software compliance in GxP is to understand exactly what the application does and how it is used.
Start by documenting:
- What is the intended use of the AI software?
- Which GxP process does it support?
- Does it influence product quality, patient safety, or regulatory decisions?
- What type of AI or machine learning technology is used?
- What data is used to train or operate the model?
- How are AI outputs generated?
- Can the model or algorithm change over time?
- What level of human review is required?
The risk of an AI application depends heavily on its intended use. An AI tool supporting a low-risk administrative activity may require different controls from an AI system influencing laboratory results, manufacturing decisions, clinical processes, or pharmacovigilance activities.
Step 2: Identify Applicable GxP Regulations and Standards
The next stage of an AI software compliance assessment is determining which regulations, standards, and guidance apply to the system.
Depending on the application and its intended use, the assessment may consider:
- 21 CFR Part 11 for electronic records and electronic signatures
- EU GMP Annex 11 for computerized systems
- GAMP 5 principles for risk-based computerized system validation
- ALCOA+ principles for data integrity
- Applicable FDA expectations
- EMA requirements and guidance
- Health Canada requirements
- MHRA expectations
- WHO guidance where applicable
Not every requirement will apply to every AI application. A risk-based assessment should determine which requirements are relevant based on the system’s functionality, GxP impact, data, and intended use.
Step 3: Review AI Software Documentation
Documentation provides evidence of how the AI software was designed, developed, tested, implemented, and maintained.
During an AI compliance review, organizations should evaluate relevant documentation such as:
- User requirements and system requirements
- Functional and technical specifications
- Validation plans and reports
- AI model development documentation
- Model training and testing information
- Training data documentation
- Data sources and data-quality records
- Risk assessments
- Standard operating procedures
- Change-control records
- System security documentation
- User manuals
- Training records
Documentation should provide sufficient evidence that the AI software is controlled throughout its lifecycle.
Step 4: Assess AI-Specific and GxP Controls
After reviewing documentation, evaluate whether the controls implemented around the AI system are appropriate and effective.
Important areas include:
Data Integrity Controls
Assess whether AI inputs, processing activities, outputs, and relevant records maintain data integrity throughout the system lifecycle.
Controls should support principles such as attribution, legibility, contemporaneous recording, originality, accuracy, completeness, consistency, and availability.
Audit Trails
Determine whether important AI-related activities are appropriately recorded. This may include changes to inputs, outputs, configurations, user activities, and model versions.
Access Controls
Review whether only authorized users can access, modify, configure, or manage the AI application and its associated data.
Model Change Control
AI models may be updated because of changes in algorithms, training data, parameters, or system configuration. Changes should be appropriately assessed, documented, tested, approved, and controlled.
Human Oversight
AI outputs should be reviewed according to the risk associated with the intended use. Organizations should define when human intervention, review, approval, or escalation is required.
Security Controls
Evaluate cybersecurity, user authentication, authorization, data protection, and other security measures relevant to the AI system.
Step 5: Identify Compliance Gaps
The AI software assessment should compare the current state of the system against applicable GxP requirements and internal quality expectations.
Common gaps may include:
- Incomplete system documentation
- Insufficient AI governance
- Weak data controls
- Inadequate model validation
- Missing or incomplete audit trails
- Poor change-control processes
- Unclear human oversight responsibilities
- Insufficient user training
- Inadequate risk assessments
- Regulatory compliance gaps
Each finding should be evaluated according to its potential impact on product quality, patient safety, data integrity, and regulatory compliance.
Step 6: Develop a Risk-Based Remediation Plan
Identifying gaps is only one part of an effective AI compliance review. Organizations should also establish a practical remediation strategy.
A remediation plan should:
- Prioritize findings according to risk.
- Assign ownership for each corrective action.
- Establish realistic completion timelines.
- Define required corrective and preventive actions.
- Update procedures and documentation where necessary.
- Implement and test required controls.
- Verify the effectiveness of completed actions.
A risk-based approach helps organizations focus resources on the AI software issues that could have the greatest GxP impact.
Common Challenges When Assessing AI Software Compliance
AI applications can create compliance challenges that are not always present in traditional computerized systems.
Changing Models
Machine learning models may change as algorithms, parameters, or training datasets are updated. Organizations therefore need appropriate lifecycle and change-control processes.
Complex Data Sources
AI applications may use large or diverse datasets. Organizations must understand where data comes from and how its quality, integrity, and suitability are maintained.
Explainability and Human Oversight
Some AI systems can produce complex outputs that are difficult to interpret. Defining appropriate human review and decision-making responsibilities is therefore important.
AI Governance
Organizations should establish clear ownership, accountability, risk management, monitoring, and lifecycle controls for AI applications used in GxP processes.
How GxP Cellators Supports AI Software Compliance Assessments
GxP Cellators provides AI software compliance assessment and GxP auditing support for organizations using AI technologies in regulated environments.
Our approach helps organizations evaluate their AI applications, identify compliance risks, review controls, and develop practical remediation strategies.
Our AI software compliance assessment services can include:
- AI software compliance assessments
- GxP AI gap assessments
- Regulatory requirement reviews
- Documentation assessments
- AI control assessments
- Data integrity assessments
- Risk assessments
- AI governance reviews
- Validation and lifecycle assessments
- Remediation planning
- Mock audit support
The assessment approach can be tailored according to the AI application’s intended use, GxP impact, technology, and regulatory requirements.
Why Choose GxP Cellators?
Assessing AI in a regulated environment requires knowledge of both GxP compliance and AI technologies. GxP Cellators combines these areas to provide practical compliance support.
Organizations can benefit from:
- GxP and AI compliance expertise
- Risk-based assessment methodologies
- Regulatory-focused reviews
- Practical and actionable recommendations
- Support for data integrity and computerized system controls
- Confidential handling of proprietary information
- Remediation-focused compliance guidance
Frequently Asked Questions
What is the first step to assess AI software compliance in GxP?
The first step is to understand the AI application’s intended use, GxP impact, functionality, data, model characteristics, and level of human oversight. This information helps determine the appropriate compliance and risk assessment approach.
What regulations may apply to AI software used in GxP environments?
Depending on the system and intended use, requirements may include 21 CFR Part 11, EU GMP Annex 11, GAMP 5 principles, data integrity expectations, and applicable FDA, EMA, Health Canada, MHRA, or WHO guidance.
What are common AI software compliance gaps?
Common gaps can include incomplete documentation, inadequate model validation, weak data integrity controls, insufficient change control, unclear human oversight, missing governance processes, and inadequate risk assessments.
Why is human oversight important for GxP AI software?
Human oversight helps ensure that AI outputs are appropriately reviewed and that important GxP decisions are not made without suitable controls. The level of oversight should be based on the system’s risk and intended use.
Can GxP Cellators help identify AI software compliance gaps?
Yes. GxP Cellators can support organizations through AI software compliance assessments, documentation reviews, gap assessments, control evaluations, data integrity reviews, and remediation planning.
Also read: AI Validation vs Traditional CSV: What GxP Auditors Need to Know
Assess Your AI Software Compliance with GxP Cellators
AI can provide significant benefits to regulated organizations, but its use must be supported by appropriate controls, documentation, validation, governance, and human oversight.
A structured AI software compliance assessment can help identify weaknesses before they become significant GxP risks. By evaluating the system from both AI and regulatory perspectives, organizations can build a more controlled and inspection-ready environment.
If you need support to assess AI software compliance in a GxP environment, contact GxP Cellators to discuss your requirements.
Contact GxP Cellators: /contact/
